I have used it maybe once a month. It does work. My wife has respiratory issues and takes it when she is struggling and it helps.
I wonder what the risk levels are with infrequent use?
]]>Have you tried to use SR9009? I have just started so I can’t speak from experience but I work where it’s sold so I’ve looked into it and it’s supposed to be good for getting rid of that stubborn bit that hangs on or for breaking a plateau.
]]>Thanks for your comment. To get answers to your health questions, please join SelfHacked VIP at https://selfhacked.lpages.co/selfhackedvip/. Feel free to get in touch with us with any questions about how our VIP members area works at [email protected].
]]>Hmmm
Given your comments fail address either the facts that author provided or the conclusions he introduced, let alone any sort of credible rebuttal in that regard, I question your true motives for writing them. Ad hominem attacks such as yours offer readers (like me) little assurance that you anything other than a condescending big Pharma shrill.
]]>Thanks for you detailed and informative response, Martin! :)
]]>I found these studies that perhaps could help as they help with AMD, as the problem there also is neovascularization growth of new blood vessels.
Just for your information to perhaps discuss with your doctors,
Atorvastatin (perhaps easier, cheaper and better than getting injection into the eyes)
(Statins also lowers one factor involved in AMD, that is called VEGF (vascular endothelial growth factor).
https://eye.hms.harvard.edu/news/patients-high-risk-macular-degeneration-show-improvement-high-dose-statin-treatment
https://www.reviewofophthalmology.com/article/amd-and-statins-is-there-an-association
And a blood pressure medicine, telmerisartan, as it seems to reduce many of the mediators involved in AMD as well (including VEGF and other factors)
Hypertension is a potential link between cardiovascular pathologies and eye diseases. A large amount of information has demonstrated the presence of a RAS (refers to how blod pressure is regulated) in the retina which is greatly spread in the vasculature. To date, findings from epidemiological studies indicate an association between AMD and hypertension. Moreover, studies in vitro and in vivo show that Ang II contributes to sub-RPE deposit formation and CNV development and that these events can be improved by Ang II receptor blockers (ARBs). However, the utility of ARBs for the treatment of eye AMD is still to be determined. In terms of DR (diabetic retinopathy), there is documented evidence showing a clear contribution of Ang II to the development of this disease. Therefore, the use of ARBs (including telmerisartan) can confer retinoprotection and arrest the progression of DR.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176806/
Study with atorvastatin with aspirin
http://www.blindness.org/treatments/cholesterol-lowering-statin-drugs-and-aspirin-show-protection-against-wet-amd
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939755/ (just aspirin for ARMD)
A animal disease model that shows telmerisartan and aspirin could work for a similar condtion that happends in the kidneys
https://www.researchgate.net/publication/41909567_Combination_of_aspirin_with_telmisartan_suppresses_the_augmented_TGFbsmad_signaling_during_the_development_of_streptozotocin-induced_type_I_diabetic_nephropathy